01 Contipro a.s. Dolní Dobrouč CZ (1)
01 Sodium hyaluronate, Type II (intrinsic viscosity: not higher than 0.70 m3/kg), from fermentation, for parenteral administration including intra-articular administration and intra-ocular use (1)
01 Czech Republic (1)
01 Valid (1)
20
Contipro A.s. Dolní Dobrouč Cz, based in Czech Republic, is a pharmaceutical company.
One of their significant offerings is Sodium hyaluronate, Type II (intrinsic viscosity: not higher than 0.70 m3/kg), from fermentation, for parenteral administration including intra-articular administration and intra-ocular use, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2010-330 - Rev 01
This Chemical Type CEP, issued on October 04, 2017, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1472 associated with this CEP further emphasizes